Axsome Therapeutics, Inc. (AXSM) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $638.50M | +65.5% |
| 2024 | $385.69M | +42.5% |
| 2023 | $270.60M | +440.8% |
| 2022 | $50.04M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $638.50M | +65.5% |
| 2024 | $385.69M | +42.5% |
| 2023 | $270.60M | +440.8% |
| 2022 | $50.04M | — |